KYTTA med crème tb 100 g

7680693930025 CH-69393 M02AX10 07.10.4.

Reimbursement limitations:

KYTTAMED.01

4 x 100 g par 3 mois

KYTTA med crème tb 100 g
KYTTA med crème tb 100 g
1 / 2
google

Details

Product number
6939301
CPT
-
Packaging group
100
Unit
g
Composition
symphyti radicis recentis extractum ethanolicum liquidum (Symphytum officinale L., radix) 350 mg corresp. ethanolum 40 mg, ratio: 1:2, solvant d'extraction ethanolum 60% (V/V), PPG-1-PEG-9 lauryl glycol ether, natrii hydroxidum q.s. ad pH, arachidis oleum raffinatum 140 mg, alcohol cetylicus et stearylicus 61 mg, aqua purificata, glyceroli monostearas 55-65, natrii laurilsulfas 1.9 mg, piceae aetheroleum, lavandulae aetheroleum, phenoxyethanolum, E 218 0.87-0.99 mg, E 214 0.22-0.26 mg, butylis parahydroxybenzoas 0.22-0.26 mg, isobutylis parahydroxybenzoas 0.10-0.14 mg, propylis parahydroxybenzoas 0.10-0.14 mg, aromatica 5.0 mg cum benzylis benzoas 3.53 mg et linaloolum et limonenum et eugenolum et hydroxycitronellalum et geraniolum et farnesolum et citralum et cumarinum et citronellolum et alcohol benzylicus 0.0002 mg, ad unguentum pro 1 g.

Articles (1)

Kytta med, crème
Crème
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
20/02/2025
Patient information leaflet
Français
20/02/2025
Patient information leaflet
Italien
20/02/2025

Detailed composition

Substance Quantity Type Category
(N/A)
350.0 MG Substance Wirkstoff (Principe actif)
(N/A)
40.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
140.0 MG Substance HBESI
(N/A)
61.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.9 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
5.0 MG Substance AROMA
(N/A)
3.53 MG Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
0.0002 MG Substance HBESI

Reimbursement information

Public price
CHF 14.35
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2024

Authorization holder

Procter & Gamble International

1213 Lancy

Authorization information

Swissmedic authorization number
69393
Drug name
Kytta med, crème
Galenic form
CREM
ATC Code
M02AX10
Authorization status
Z
Authorization category
Category C
Dispensation category
D
First authorization
07/07/2023
Authorization expiration date
31/12/9999
IT number
07.10.4.
Domain
Human medicine
Field of application
Bei rheumatischen Erkrankungen und stumpfen Verletzungen

Packaging details

Description (FR)
KYTTA med crème tb 100 g
Description (DE)
KYTTA med Creme Tb 100 g
Market launch
07/07/2023
Narcotic (BTM)
No